{
  "parties": [
    "Pfizer Inc.(“Pfizer”), a Delaware corporation, with a principal place of business at 235 East 42nd Street, New York, New York 10017",
    "Exact SciencesCorporation (“Exact”)"
  ],
  "effective_date": null,
  "governing_law": "Delaware",
  "payment_terms": null,
  "termination_clause": {
    "text": "termination of thisAgreement.(c) Right of First Negotiation.(i) During the Term, if Exact (i) enters a formal process authorized or directed by its board of directors or CEO to seek andenter into an arrangement or (ii) intends to agree to a term sheet or seeks to sign a letter of intent or similararrangement to grant an exclusive commercial license to a Third Party solely to promote or sell the Productoutside the Territory (“Ex-US Commercial Rights”), Exact shall first notify Pfizer of such intent (a “Ex-USCommercial Rights Transfer Notice”) and Pfizer shall have thirty (30) days thereafter to notify Exact of itsdesire to obtain the Ex-US Commercial Rights that are the subject of the Ex-US Commercial Rights TransferNotice. Promptly upon receipt of notice from Pfizer, Exact and Pfizer shall engage in",
    "start": 50605,
    "end": 51416,
    "confidence": 0.72,
    "source": "regex"
  },
  "_doc_id": "Part_I__Promotion__ExactSciencesCorp_20180822_8-K_EX-10.1_11331629_EX-10.1_Promotion Agreement.txt",
  "_char_count": 156985,
  "_provenance": {
    "governing_law": {
      "source": "spacy"
    }
  },
  "_issues": [
    {
      "type": "MISSING",
      "field": "payment_terms"
    }
  ]
}